Under the All in AI strategy, Meinian Health continues to launch specialized new products, uses AI to carry out efficient marketing, and continues to refine operations. In 2023, Meinian Health will generate approximately 9% of its revenue through innovative products, and the company's annual revenue will exceed 10 billion for the first time.
Three years ago, Meinian Health proposed the “All in Digital” strategy. In 2024, the company will upgrade it to "All in AI". At present, Meinian Health’s AI layout is mainly reflected in the continuous launch of specialized new products, the use of AI to empower marketing and refined operations, the reshaping of the physical examination chain through AI empowerment, and the release of the first domestic private AI based on large-scale model technology. Health manager - four aspects of health and beauty. In mid-October, Meinian Health President Xu Tao gave a detailed analysis of Meinian Health’s AI layout in recent years in an exclusive interview with Jiemian News.
Product layer: Continuously launch high-quality AI physical examination projects
Meinian Health’s first layer of All in AI layout is to continuously launch AI products.
Since its development, Meinian Health has launched many specialized and new products to the public, such as Feijie Ning, Naoruijia, Coronary Artery Calcification Points, etc. In Meinian Health, the company calls the products it launches using AI technology special new products.
As the industry's first comprehensive management service project for pulmonary nodules, Feijiening is one of the most representative products in the implementation of Meinian Health's "All in AI" strategy.
In fact, Meinian Health started auxiliary diagnosis of pulmonary nodules in 2017. After a large amount of practice accumulation, in 2022, the company launched the comprehensive lung health service package Fei Jie Ning. Fei Jie Ning includes comprehensive seven-type lung cancer antibody blood tests, imaging E+ retrospective pulmonary nodule in-depth analysis reports, lung health service packages, and lung malignant tumor insurance.
The popular understanding is that if the subject chooses this product, once a small pulmonary nodule is discovered during the examination, he or she can receive services that go beyond detection, such as report interpretation, lung cancer risk assessment, and even lung cancer diagnosis and treatment services, etc. As a result, through the product Feijiening, we can realize full-link services of early lung cancer screening, early diagnosis, follow-up management, and lung cancer diagnosis and treatment intervention. Moreover, this series of services also fully adheres to the clinical standard lung health protection system.
After Fei Jie Ning, Meinian Health also launched “Nao Ruijia” in 2022. This is another typical product in the implementation of Meinian Health’s “All in AI” strategy. It is also the first brain health screening product on the market for stroke and Alzheimer’s (AD).
In the product Nauruijia, Meinian Health can not only provide MRI, a scarce service in the market, but also create a brain standard library of more than 100,000 healthy people based on an average of tens of millions of healthy people per year. After comparing MRI and standard libraries, Nauruijia can also use AI image technology to predict risks and assess the subject's brain health risk status.
It is worth mentioning that Naoruijia has high-precision brain magnetic resonance imaging technology. Compared with head MRI, it improves the scanning resolution and image analysis sensitivity, and can detect small abnormal indicators in the early stage of the disease.
Currently, in the Naoruijia project, all groups over the age of 20 can be screened, and people aged 30-55 are screened as a key group, which can reveal the entire structural disease and the risk of degenerative functions in advance. For people over 55 years old, Naoruijia can reveal their risks of brain cognition and Alzheimer's disease 5-10 years in advance.
It is not difficult to see that Meinian Health’s specialized and new products always accurately meet market demand. Lung cancer is a malignant tumor with the highest morbidity and mortality in China. Since the COVID-19 epidemic, public attention to lung health has continued to increase.
In terms of brain health, the diagnosis status of AD is not optimistic, which increases the burden of AD on patients and society. Jia Jianping's team at Xuanwu Hospital of Capital Medical University published a study in "Alzheimer's & Dementia" - the per capita annual cost of AD patients in China was US$19,000 in 2015, and the total domestic socioeconomic burden caused by AD reached US$167.74 billion.
Up to now, Feijiening has served more than 100,000 people, and its products have covered more than 130 cities; Naoruijia has screened more than 200,000 people, and its products have covered more than 220 cities, with a detection rate of medium and high-risk abnormalities. 14%.
In addition to Feijiening and Naoruijia, on August 28 this year, the 20th anniversary of Meinian Health, the company also released innovative AI intelligent blood glucose management products. Behind this product is also combined with the sugar control plan developed by Academician Jia Weiping, an academician of the Chinese Academy of Engineering, and his team.
Blood sugar management is a matter of great importance in the domestic medical field. In July this year, the National Health Commission jointly released the "Healthy China Action-Diabetes Prevention and Control Action Implementation Plan (2024-2030)" with multiple departments, which included diabetes prevention and control into the Healthy China special action. Currently, China has more than 140 million diagnosed patients with diabetes, ranking first in the world. At present, the AI blood glucose monitoring and management products released by Meinian Health also have strong market potential.
In terms of calcium scores and cardiopulmonary screening, Meinian Health has launched a project to automatically identify the calcification of branch blood vessels in CT chest images based on artificial intelligence technology and an average of more than 10 million CT scans per year to provide screening for coronary heart disease in asymptomatic people. in accordance with. The so-called "calcification score" usually refers to the coronary artery calcium score, which is a quantitative score based on the observation of the degree of coronary artery calcification lesions through CT examination.
At present, the market response to calcium score and cardiopulmonary screening service projects is also very good. Up to now, the number of users of the product has exceeded 5.5 million, the product covers more than 300 cities, the positive detection rate is 16.5%, and the number of major abnormalities is 2.3%. In addition, Meinian Health is also trying to use AI to assist traditional Chinese medicine. In response to the problems of standardization and difficulty in copying traditional Chinese medicine, Meinian Health is strengthening the intelligent physical examination of traditional Chinese medicine by putting in intelligent equipment.
Operation layer: Refined operations and digital marketing based on AI
In addition to products, Meinian Health’s second layer of AI layout is refined operations and digital marketing.
Meinian Health uses AI to conduct refined operations. From a company business perspective, Meinian Health is equivalent to a large national chain physical examination group. Compared with other types of chain-operated companies, medical services are more difficult to standardize. Based on this, how to ensure that every physical examination institution under its umbrella has excellent service levels is a problem facing operators. At present, Meinian Health is trying to use AI to solve this problem.
Xu Tao said in an interview that Meinian Health is currently using AI to carry out quality control of medical services throughout the entire diagnosis, treatment and physical examination process. This not only includes AI-assisted diagnosis, such as using AI technology in the auxiliary diagnosis of breast cancer, thyroid cancer, and pulmonary nodules to improve doctors’ reading efficiency and accuracy, but also includes the use of AI in the entire service process. Among them, the application of AI technologies such as time-sharing appointments and intelligent medical guidance can improve consumers’ experience.
It is worth noting that the reason why Meinian Health is able to achieve refined operations and greatly improve the company's management of medical quality is because it currently uses a set of systems called "Bianque Intelligent Physical Examination Management System."
In July 2022, Meinian Health officially launched the self-developed Bianque Intelligent Physical Examination Management SaaS cloud platform, which for the first time in the 20-year development history of Meinian Health achieved digital and intelligent management of the entire physical examination process. The launch of the Bianque system is also an important carrier of Meinian Health's digital transformation, laying a solid foundation for the group to build a comprehensive, full life cycle digital health management in the next stage.
Specifically, through the Bianque system, Meinian Health has realized the functions of time-sharing appointment, quick registration, smart guidance, intelligent addition of items, error correction during examination, real-time data exchange, sample tracking and other functions of physical examination business, covering all aspects of physical examination. The whole process. Because the system can automatically report important abnormal results, support one-click reporting of important abnormal results for examinations, and conduct random inspections of physical examination reports, it strengthens medical quality management.
In addition, Bianque System and its sub-project Queqiao completed the automatic docking of inspection equipment in the physical examination business, forming a connection between the physical examination business and physical examination equipment, improving the efficiency of Meinian Health's physical examination business. The Bianque system can also realize real-time cloud interaction between the physical examination cloud platform and the medical technology cloud platform, allowing real-time data exchange to enhance the quality of medical diagnosis. Therefore, based on the Bianque system and after carrying out refined operation management, Meinian Health has achieved data-driven, efficient collaboration and accurate business decision-making support.
For consumers, after the application of such a system, the physical examination service experience obtained at Meinian Health will also be greatly improved.
For example, through smart time-sharing appointment and smart consultation functions, consumers can conveniently make physical examination appointments and reduce waiting; through real-time data exchange and sample tracking functions, consumers can obtain personal physical examination results more timely and accurately, avoiding information omissions or errors. . And by obtaining abnormal results in a timely manner, you can also enjoy better personalized services. In addition, after getting the report and getting intelligent interpretation, consumers can also get a series of follow-up health management, so they can manage their health more conveniently.
Xu Tao also emphasized in the interview that the launch of the Bianque Intelligent Physical Examination Management SaaS cloud platform is not a one-time thing. It is only the first step. Meinian Health will continue to improve the business of the entire physical examination process in the future and continuously optimize the process through data drive. , improve efficiency, and strive to ensure medical quality and service quality.
In terms of digital marketing, Meinian Health is building a sales team powered by AI. According to Xu Tao, Meinian Health has 16,000 sales and health management personnel nationwide. Meinian Health has selected the top 10% of the most experienced personnel and used their experience in AI training, including consultation and response skills for physical examination services. .
In this way, after using AI in Meinian Health's marketing system, it is equivalent to comprehensively improving the business level of these 16,000 sales staff. At the same time, the use of AI to conduct medical professional knowledge transfer, sales skills training, and innovative single product information implantation for sales staff has also greatly reduced the cost of human training and improved the team's overall professional medical service level.
More importantly, AI-based assistance can quickly increase the conversion rate of potential customers. The C-side performance growth direction of Meinian Health is "group transfer" and private domain customer operations." Based on AI blessing, it can be controlled in On the basis of operating costs, customer service quality and customer conversion rate have been greatly improved.
In addition, Xu Tao also mentioned in the interview that in the second quarter of 2024, Meinian Health’s AI intelligent sales assistant “Meinian Xiaoxing” based on large-scale model technology has been piloted in Hangzhou, and “Meinian Xiaoxing” has been launched in the AI sales agency During the one-month test period of the operation project, through the Qiwei account, the sales transaction conversion rate reached 8.02%, and the average customer price increased reached 1,492.27 yuan.
Xu Tao believes that with the all-round iteration and improvement of the AI voice system in the future, Meinian Health’s sales assistant can also comprehensively improve the professionalism, timeliness and conversion rate of physical examination consultation, and boost the growth of C-end customers.
Industry level: AI reshapes physical examination and can be used in all aspects before, during and after examination
On August 28 this year, at the company's 20th anniversary celebration, Meinian Health, together with Huawei and Runda Medical, officially launched China's first health management AI robot - Healthy Xiaomei. It is also an important achievement of Meinian Health's comprehensive implementation of the "All in AI" strategy, and also represents a key step for Meinian Health in the field of digital intelligent health management.
Health Xiaomei is the first domestic AI intelligent personal health manager released based on large-scale model technology. It brings a new health management model to consumers and is a good start for the personalized and digital development of the physical examination industry. Health Xiaomei has done a good job in responding to the three major trends of real-time consultation on personal health issues, comprehensive understanding of health data trends, and personalized health management plans.
Meinian Health summarizes the functions it can carry as "five completes". The so-called "five completes" include full-process high-quality services, full life cycle digital health files, all-round personalized health plans, all-weather professional health consultation, all-round Interactive multimodal perception fusion.
Specifically, "Healthy Beauty" empowers users before, during and after examination, providing users with full-process, high-quality services, including: professional interpretation of pre-examination inspection items, exclusive customization of physical examination packages, and warm reminders on examination guides; Intelligent diagnosis during the examination reduces waiting, real-time reminders of abnormal results, and intelligent recommendations for in-depth examinations; after the examination, a full life cycle health file, personalized health advice, and round-the-clock health consultation are established.
"Healthy Beauty" relies on advanced large model technology to build structured, standardized and normalized full life cycle digital health files for users. In addition, "Healthy Beauty" can evaluate the user's health status based on the user's personal health profile, combined with age, family history, living habits, etc., and provide users with personalized health intervention methods from aspects such as exercise, diet, and psychology. It provides personalized medical treatment plan guidance, covering medical treatment time limit, treatment departments and green pass services.
As a health management AI robot, "Healthy Xiaomei" can respond to users' needs at any time and provide them with 24-hour considerate companionship. It meets users' health needs in real time through multi-modal interaction methods such as text, images, voice, and video; through The three-dimensional digital twin that visualizes individual health status reminds users of their health status in real time; it can also proactively remind users to execute health plans on time through smart wearable devices, bringing users a new way of fully interactive health management.
Behind this lies the technological, medical and brand power of Health Xiaomei. Compared with other general large models, Healthy Xiaomei learned from the 20 years of industry experience accumulated by 35,000 Meinian health preventive medicine talents during the research and development process, as well as over 100 million-level structured health data.
Health Xiaomei also received dual empowerment from Huawei’s Pangu model and Runda Medical model. Among them, Huawei's Pangu large model 5.0 P series is equipped with Shengteng AI cloud service, which can provide a sustainable AI computing power base and low-latency, high-efficiency inference services, and can identify medical records, physical signs, examinations, ECG, Multi-modal data such as ultrasound, CT, and NMR, and can accurately understand the meaning of the data.
In addition, with the support of Pangu Guard technology, it can create multiple security lines of defense for Healthy Xiaomei in data governance, model security and content compliance, and better meet the data transmission and privacy protection requirements under higher industry standards. Runda Medical uses cutting-edge data governance, RAG, MoE, AI agent and other technologies based on the Pangu large model to continuously improve and optimize the large model to make it more suitable for the complex needs of medical and health management.
Xu Tao proposed that based on Health Xiaomei, Meinian Health can also expand a series of value-added services such as post-examination specialist genetic testing, chronic disease management, and health insurance. While integrating industry resources, Meinian Health can provide one-on-one and personalized health care. Management services, specialized and chronic disease health management services, to better explore the potential of the physical examination business.
Performance level: AI helps performance continue to achieve breakthroughs
At present, “All in AI” has helped Meinian Health improve its performance. The AI layout has brought real performance transformation to Meinian Health.
Xu Tao said in the interview that in the past two or three years, the company's operations have been significantly boosted based on the application of AI in corporate operations and the launch of innovative, specialized and special new products. In the past three years, Meinian Health's unit price has continued and steadily increased. Especially in 2022 and 2023, the group's unit price has increased by double digits every year.
In 2023, Meinian Health will generate approximately 9% of its revenue through innovative products. In 2023, as a listed company, Meinian Health achieved revenue exceeding 10 billion for the first time - the company achieved revenue of 10.9 billion yuan during the period, a year-on-year increase of 26%; the number of company inspections increased by 13%, and the unit price per customer increased by 11%. Both volume and price increased, and the net profit in the same year exceeded 500 million yuan.
In the first three quarters of this year, the AI specialized new product series, including products such as Fei Jie Ning, Nao Ruijia, coronary artery calcium score, AMD multidisciplinary expert intelligent health system, and digital cloud film, have achieved sustainable and rapid growth. , also fully demonstrated Meinian’s innovation capabilities and market competitiveness in the field of artificial intelligence.
In the interview, Xu Tao proposed that Meinian Health will undergo four core changes in the next round of development - in terms of product solutions, it will be upgraded from the previous fixed package model to personalized, customized, and intelligent solutions; in terms of service frequency, it has transformed from low-frequency single physical examination consumption to a comprehensive, full life cycle sustainable health consumption model; in terms of business model, it has changed from a traditional business model that is more dependent on scale, equipment, and cost-effectiveness. It has been upgraded to a discipline-building business model driven by brand, data, and academics; in terms of management model, through AI layout, it has transformed from a labor-intensive traditional chain management model to a comprehensive digital-intelligent active health service model.
It is worth noting that in the future, discipline construction will be the key direction and important strategic support of Meinian Health. We hope to use this to achieve the company's differentiated competitive advantages, especially in the fields of ultrasound intelligence, brain science, and respiratory science. Competitive advantages in key disciplines such as lung health, digestive tract examination, breast and cervical screening, intelligent main examination and blood sugar management.
Among them, digital ultrasound quality control is an important area that Meinian Health focuses on. Xu Tao believes that as far as physical examinations are concerned at this stage, ultrasound is still a relatively bottlenecked department. In this regard, Meinian Health is carrying out intelligent upgrades in all aspects before, during and after examination, striving to improve the detection rate and accuracy, reduce the misdiagnosis rate and eliminate the missed diagnosis rate.
In terms of the digestive system, Meinian Health introduced the magnetically controlled capsule gastroscopy robot seven years ago, and this product is still an industry-leading product. At the same time, Meinian Health will apply genetic testing-based bowel cancer screening products to achieve early screening of the entire digestive tract. The endoscopy center established by the company also makes it easier for subjects to complete comfortable, comprehensive and accurate gastrointestinal examinations.
In terms of two female cancers, breast cancer and cervical cancer will be listed as key early screening areas. Meinian Health uses three-dimensional breast volume ultrasound, and also adds AI-assisted diagnosis and a remote cloud diagnosis quality control system to help achieve breast cancer diagnosis. Accurate early screening and diagnosis of cancer. For early screening of cervical cancer, Meinian Health has launched the HPV1617 protein detection project, which can target the oncogenic protein produced by the HPV virus and achieve a full-cycle, systematic, non-invasive and in-depth examination of cervical cancer. In addition, the aforementioned Naoruijia, Feijiening, Healthy Xiaomei, and blood sugar management will all be the continued focus of Meinian Health in the future.
Based on current achievements, Xu Tao also proposed Meinian Health’s vision for AI, which mainly includes five aspects: first, research and develop new technologies, continue to increase investment in AI technology research and development, and continue to launch specialized and new AI Innovative products; second, continue to build new platforms and deepen multi-party cooperation to meet the increasingly diverse health needs of customers, including management of the entire physical examination process, as well as in-depth cooperation with partners such as hospitals, insurance companies, and health management centers; third Third, continue to implement refined operations and continue to empower with "AI + medical care"; fourth, establish new standards, participate in the standard formulation of AI technology, and lead the standardized development of the industry; fifth, build a new ecology of health management AI, promote products and Innovation in service models.
Xu Tao said that this year marks the 20th anniversary of the establishment of Meinian Health. At this point in time, the company has very clearly seen the challenges of the entire industry, and also very keenly felt the opportunities of the times brought by the iterative wave of AI and large model technology. As the largest health data portal in China, Meinian Health has more confidence, more opportunities, and more ability than ever before to upgrade the company from a leading company in the prevention field to a comprehensive, full life cycle digital health management leader. .